Myriad Genetics
MYGN
MYGN
270 hedge funds and large institutions have $2.38B invested in Myriad Genetics in 2013 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 109 increasing their positions, 90 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
9% less capital invested
Capital invested by funds: $2.62B → $2.38B (-$245M)
74% less call options, than puts
Call options by funds: $43.4M | Put options by funds: $168M
Holders
270
Holding in Top 10
2
Calls
$43.4M
Puts
$168M
Top Buyers
| 1 | +$60.7M | |
| 2 | +$46.1M | |
| 3 | +$39.6M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$32.2M |
| 5 |
SCM
Snow Capital Management
Sewickley,
Pennsylvania
|
+$32M |
Top Sellers
| 1 | -$173M | |
| 2 | -$45.6M | |
| 3 | -$45.2M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$26.2M |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$24.3M |